MHRA ‘assessing reports’ of respiratory illness outbreak linked to e-cigarettes in the United States The Medicines and Healthcare products Regulatory Agency is reviewing information about a respiratory illness that has been linked to e-cigarette use in the United States.…
HRT stock update shows that supply problems are set to continue into 2020 The Department of Health and Social Care has said that six hormone replacement therapy products will be out of stock for the foreseeable future, with others facing ongoing problems well into 2020.…
Half of all safety warnings issued to drug manufacturers in India and China The majority of warnings from European and US drug regulators are to drug manufacturing sites in India and China, raising concerns about the fragility of the global supply chain.…
Hair dye allergy test is first to be switched from prescription only The first allergy test for hair dye to be formally reclassified from a prescription-only medicine to a general sale list medicine has been switched, the Medicines and Healthcare products Regulatory Agency has announced.…
MHRA has taken action against companies on FMD compliance The Medicines and Healthcare Regulatory Agency has confirmed that it has taken regulatory action against a small number of companies for infringements relating to compliance with the Falsified Medicines Directive.…
It is time to enforce FMD compliance, says European Medicines Verification Organisation The body that runs the Falsified Medicines Directive says medicines regulators in individual countries should begin enforcing its compliance.…
MHRA warns patients about potential failure of Emerade adrenalin auto-injectors Some Emerade adrenaline auto-injectors may fail to deliver a dose of adrenaline from the syringe owing to a blockage in the needle, the Medicines and Healthcare products Regulatory Agency has warned.…
EMA launches ‘urgent safety review’ of alemtuzumab after two patient deaths The European Medicines Agency (EMA) has launched a safety review of alemtuzumab following reports of two deaths and several other cases of people experiencing life-threatening reactions shortly after taking the medicine.…
MHRA issues drug alert for prednisolone tablets after dosage mislabelling in Braille The Medicines and Healthcare products Regulatory Agency has issued a warning not to supply prednisolone from five batches of 5mg tablets to patients with sight problems following a Braille misprint on the packaging.…
All opioid medicines to contain clear warnings about addiction, health secretary announces All opioid medicines will need to carry prominent warnings about the risk of addiction, health and social care secretary, Matt Hancock, has announced.…